OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphoma

Published:2023-06 Issue: Volume:251 Page:109637
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Lu Yaxiao,Li Yang,Yu Jingwei,Meng Shen,Bi Chengfeng,Guan Qingpei,Li Lanfang,Qiu Lihua,Qian Zhengzi,Zhou Shiyong,Gong Wenchen,Meng Bin,Ren Xiubao,Armitage James,Zhang Huilai,Fu Kai,Wang Xianhuo

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference42 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms;Swerdlow;Blood.,2016

2. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d’Etudes des Lymphomes de l’Adulte;Coiffier;Blood.,2010

3. Immune checkpoint blockade in cancer therapy;Postow;J. Clin. Oncol.,2015

4. Nivolumab for relapsed/refractory diffuse large B-cell lymphoma in patients ineligible for or having failed autologous transplantation: a single-arm, phase II study;Ansell;J. Clin. Oncol.,2019

5. The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy;Buchan;Blood.,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TIGIT: Will it be the next star therapeutic target like PD-1 in hematological malignancies?;Critical Reviews in Oncology/Hematology;2024-09

2. Establishment of novel anti-TIM-3 antibodies interfering with its binding to ligands;Heliyon;2024-04

3. Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00;European Journal of Cancer;2024-03

4. Diffuse large B-cell lymphoma: the significance of CD8+ tumor-infiltrating lymphocytes exhaustion mediated by TIM3/Galectin-9 pathway;Journal of Translational Medicine;2024-02-18

5. Prognostic analysis of prostaglandin D2 synthase in diffuse large B-cell lymphoma;Holistic Integrative Oncology;2023-10-26